TrianglePUBLICATIONS · 12200353
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2002 Sep 15
- First author
- Ottmann OG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ottmann OG
- type
- Author
- name
- Druker BJ
- type
- Author
- name
- Sawyers CL
- type
- Author
- name
- Goldman JM
- type
- Author
- name
- Reiffers J
- type
- Author
- name
- Silver RT
- type
- Author
- name
- Tura S
- type
- Author
- name
- Fischer T
- type
- Author
- name
- Deininger MW
- type
- Author
- name
- Schiffer CA
- type
- Author
- name
- Baccarani M
- type
- Author
- name
- Gratwohl A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ottmann OG
- type
- Author
- name
- Druker BJ
- type
- Author
- name
- Sawyers CL
- type
- Author
- name
- Goldman JM
- type
- Author
- name
- Reiffers J
- type
- Author
- name
- Silver RT
- type
- Author
- name
- Tura S
- type
- Author
- name
- Fischer T
- type
- Author
- name
- Deininger MW
- type
- Author
- name
- Schiffer CA
- type
- Author
- name
- Baccarani M
- type
- Author
- name
- Gratwohl A
- type
- Author
- bibliography ids
- nci-bib-3ff0ae28bab8a311e9f35ce6
- book metadata
- content sha256
- 2c301fa0933b41b59119e35fedf16ea56b947debc6d6ef4f5e8f7a1a7b1067e0
- document type
- citation
- dois
- 10.1182/blood-2001-12-0181
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12200353
- immutable id
- pubmed:12200353@2c301fa0933b41b59119e35fedf16ea56b947debc6d6ef4f5e8f7a1a7b1067e0
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 6
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1965-71
- volume
- 100
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12200353
- provenance
- batch id
- ced7794d3512d3f45188
- provider
- NCBI PubMed ESummary
- record sha256
- 077b6aa589ec8d0892dee913ed5a73b13221ecabcc97b29d830ee234e1cbac7f
- response sha256
- 782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
- retrieved at
- 2026-09-09T23:45:46.208577+00:00
- publication date
- display
- 2002 Sep 15
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
Preserved source evidence · Not medical advice